Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept study of terguride in systemic sclerosis-related fibrosis
2009-017869-27Phase 2Active
- Sponsor
- University Hospital Zurich
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of terguride in systemic sclerosis (SSc), sponsored by University Hospital Zurich. Primary endpoints: Change in skin biopsy biomarkers, Change in plasma and serum biomarkers and 1 more. Started Jul 2010; status: active.
02
Drugs
terguride
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on 2009-017869-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017869-27.